Unlock your financial potential trading stocks!
November 14, 2019 by Kevin Douglass
November 13, 2019 by Sultan Beardsley
November 6, 2019 by Sultan Beardsley
Futures Prices (%) Futures By : MS Money Moves 1) NGM $12.95 Closed rather unchanged but saw more form 4s. The purchase amount was 15 shares. Some are speculating that this may … [Read More...] about Trade-Ideas, Thursday, Nov. 14th, 2019
On September 25th, 2019 the MS Money Moves Executive Leadership Team had an hour long conference call with President and CEO of DelMar Pharmaceuticals (Nasdaq: DMPI) Saiid Zarrabian and acting Chief … [Read More...] about Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
Bellicum Pharmaceuticals (NASDAQ: BLCM) has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bottom (starting Aug 2019 to current) and with very successful … [Read More...] about BLCM #VolatilityWatch
Trade Summary Ticker: NGM (Last: $13.01) Entry: $12.70-13.0 Price Target: $14.50-20.00 Target Time-frame: 1-8 weeks Source: Trading View Trade Thesis NGM recovered as I … [Read More...] about NG-mother-effin-M
Marker Therapeutics (Nasdaq: MRKR) may be showing signs of life after testing key Fibonacci level of support. Chart: Harmonic Butterfly;Double bottom CCI moved positive (inferring bulls … [Read More...] about Marker Therapeutics: Bulls Loading
Scynexis (NASDAQ: SCYX) is a clinical stage biotech company based out of New Jersey. The company has one significant drug under development in multiple indications, ibrexafungerp, for the treatment of … [Read More...] about In a Tough Environment for Biotechs, Can the Science at Scynexis Win?
*90% Of Traders
Lose Money
*100% DON'T
Have To
At MS Money Moves we leverage our teams expertise in science, business, and technical analysis identifying gainful biotech trades.
How we do it?
Patience, Discipline, Objective Analysis.
See our performance record for more info.
Try it for free, Let's get it!
